These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24044099)

  • 1. Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer.
    Shim UJ; Lee IS; Kang HW; Kim J; Kim WT; Kim IY; Ryu KH; Choi YH; Moon SK; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Korean J Urol; 2013 Sep; 54(9):631-7. PubMed ID: 24044099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kim K; Byun YJ; Zheng CM; Moon S; Jo SJ; Kang HW; Kim WT; Choi YH; Moon SK; Kim WJ; Piao XM; Yun SJ
    Investig Clin Urol; 2024 Jan; 65(1):94-103. PubMed ID: 38197756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix Metalloproteinases -2 and -9, Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor and CD105- Micro-Vessel Density are Predictive Markers of Non-Muscle Invasive Bladder Cancer and Muscle Invasive Bladder Cancer Subtypes.
    Siddhartha R; Goel A; Singhai A; Garg M
    Biochem Genet; 2024 Sep; ():. PubMed ID: 39311994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium.
    Lopez-Beltran A; Alvarez-Kindelan J; Luque RJ; Blanca A; Quintero A; Montironi R; Cheng L; Gonzalez-Campora R; Requena MJ
    J Pathol; 2008 Jul; 215(3):263-72. PubMed ID: 18452128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer.
    Piao XM; Kang HW; Jeong P; Byun YJ; Lee HY; Kim K; Seo SP; Kim WT; Lee JY; Ha YS; Choi YH; Moon SK; Yun SJ; Kim WJ
    Urol Oncol; 2021 Apr; 39(4):237.e21-237.e29. PubMed ID: 33339725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study.
    Dyrskjøt L; Reinert T; Algaba F; Christensen E; Nieboer D; Hermann GG; Mogensen K; Beukers W; Marquez M; Segersten U; Høyer S; Ulhøi BP; Hartmann A; Stöhr R; Wach S; Nawroth R; Schwamborn K; Tulic C; Simic T; Junker K; Harving N; Petersen AC; Jensen JB; Keck B; Grimm MO; Horstmann M; Maurer T; Steyerberg EW; Zwarthoff EC; Real FX; Malats N; Malmström PU; Ørntoft TF
    Eur Urol; 2017 Sep; 72(3):461-469. PubMed ID: 28583312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
    Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
    Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer.
    Ha YS; Kim MJ; Yoon HY; Kang HW; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Korean J Urol; 2010 Jan; 51(1):15-20. PubMed ID: 20414404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel tumor suppressing gene,
    Piao XM; Jeong P; Yan C; Kim YH; Byun YJ; Xu Y; Kang HW; Seo SP; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Cha EJ; Yun SJ; Kim WJ
    Oncol Lett; 2020 Jan; 19(1):476-486. PubMed ID: 31897161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer.
    Yun SJ; Jo SW; Ha YS; Lee OJ; Kim WT; Kim YJ; Lee SC; Kim WJ
    Urol Oncol; 2012; 30(6):893-9. PubMed ID: 21396842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer.
    Kang HW; Yoon HY; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Korean J Urol; 2012 Sep; 53(9):598-606. PubMed ID: 23060996
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Pignot G; Le Goux C; Vacher S; Schnitzler A; Radvanyi F; Allory Y; Lallemand F; Delongchamps NB; Zerbib M; Terris B; Damotte D; Bieche I
    Oncol Lett; 2019 Oct; 18(4):3471-3480. PubMed ID: 31516565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: a novel approach using peptide nucleic acid-mediated, real-time PCR clamping.
    Kim EJ; Yan C; Ha YS; Jeong P; Yi Kim I; Moon SK; Choi YH; Kim WJ
    Urol Oncol; 2012 Sep; 30(5):673-9. PubMed ID: 20884250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.
    Silva TA; Azevedo H
    J Proteomics; 2020 Oct; 229():103951. PubMed ID: 32860965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.
    Kim EJ; Lee YS; Kim YJ; Kim MJ; Ha YS; Jeong P; Lee OJ; Kim WJ
    Urology; 2010 Jun; 75(6):1516.e9-13. PubMed ID: 19913893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer.
    Gou Y; Ding W; Xu K; Wang H; Chen Z; Tan J; Xia G; Ding Q
    Int Urol Nephrol; 2015 Feb; 47(2):289-93. PubMed ID: 25388353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of spindle and kinetochore- associated protein 1 predicts early recurrence and progression of non-muscle invasive bladder cancer.
    Jiang S; Tian F; Wang Q; Cheng W; Wang L; Wang Y; Sun W
    Cancer Biomark; 2018; 22(3):543-549. PubMed ID: 29865039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-gene signature predicts disease progression of non-muscle invasive bladder cancer.
    Jeong P; Ha YS; Cho IC; Yun SJ; Yoo ES; Kim IY; Choi YH; Moon SK; Kim WJ
    Oncol Lett; 2011 Jul; 2(4):679-684. PubMed ID: 22848249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of SAM68 in the progression and prognosis for bladder cancer.
    Zhang Z; Yu C; Li Y; Jiang L; Zhou F
    BMC Cancer; 2015 May; 15():364. PubMed ID: 25944080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.